Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SIMULATIONS PLUS, INC.

(SLP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

SIMULATIONS PLUS, INC. : Ex-dividend day for

07/23/2021 EDT

A dividend is removed today from Simulations Plus, Inc.'s share.



ę Factset 2021
All news about SIMULATIONS PLUS, INC.
09/23SIMULATIONS PLUS : Receives New Grant Award From the FDA
BU
09/23Simulations Plus Receives New Grant Award from the FDA
CI
09/21SIMULATIONS PLUS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form..
AQ
09/15SIMULATIONS PLUS : Releases ADMET Predictor« (X.3)
BU
09/15Simulations Plus, Inc. Releases Version 10.3 of its Machine Learning Modeling Platform
CI
09/08SIMULATIONS PLUS : to Participate in BofA Securities and Oppenheimer Investor Conferences
BU
08/19SIMULATIONS PLUS : Reports Continued Success in Second Phase of AIDD Collaboration with La..
BU
08/19Simulations Plus Reports Continued Success in Second Phase of AIDD Collaboration with L..
CI
08/04SIMULATIONS PLUS : NMPA's Center for Drug Evaluation Adds Licenses of GastroPlus«
BU
08/04Simulations Plus, Inc. Receives an Order from the Center for Drug Evaluation of the Nat..
CI
More news
Analyst Recommendations on SIMULATIONS PLUS, INC.
More recommendations
Financials (USD)
Sales 2021 44,8 M - -
Net income 2021 10,5 M - -
Net Debt 2021 - - -
P/E ratio 2021 77,7x
Yield 2021 -
Capitalization 790 M 790 M -
Capi. / Sales 2021 17,6x
Capi. / Sales 2022 15,1x
Nbr of Employees 133
Free-Float 77,7%
Chart SIMULATIONS PLUS, INC.
Duration : Period :
Simulations Plus, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SIMULATIONS PLUS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Last Close Price 39,22 $
Average target price 64,67 $
Spread / Average Target 64,9%
EPS Revisions
Managers and Directors
Shawn M. O'Connor Chief Executive Officer
William W. Frederick Chief Financial Officer & Secretary
Walter S. Woltosz Chairman
Viera Lukacova Chief Scientist
David L. Ralph Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SIMULATIONS PLUS, INC.-46.16%790
VEEVA SYSTEMS INC.8.33%45 246
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED-51.97%19 050
OMNICELL, INC.27.97%6 677
PRO MEDICUS LIMITED69.67%4 407
SECTRA AB (PUBL)28.83%4 183